# Syncope Evaluation

**VERSION:** 1.0
**CREATED:** January 29, 2026
**REVISED:** January 29, 2026
**STATUS:** Complete

---

**DIAGNOSIS:** Syncope

**ICD-10:** R55 (Syncope and collapse), T67.1 (Heat syncope), G90.01 (Carotid sinus syncope), I95.1 (Orthostatic hypotension)

**SYNONYMS:** Syncope, fainting, loss of consciousness, passing out, blackout, vasovagal syncope, neurocardiogenic syncope, reflex syncope, orthostatic syncope, cardiac syncope, convulsive syncope

**SCOPE:** Evaluation and management of transient loss of consciousness (TLOC) due to syncope in adults. Includes risk stratification, etiologic workup, and treatment by type. Applies to ED, hospital, and outpatient settings. Excludes seizure, stroke, metabolic causes, and traumatic loss of consciousness.

---

**DEFINITIONS:**
- **Syncope:** Transient loss of consciousness (TLOC) due to transient global cerebral hypoperfusion; characterized by rapid onset, short duration, and spontaneous complete recovery
- **Presyncope:** Prodromal symptoms (lightheadedness, warmth, nausea) without loss of consciousness
- **Reflex (Neurally-Mediated) Syncope:** Most common; includes vasovagal, situational, carotid sinus syncope
- **Orthostatic Syncope:** Due to orthostatic hypotension from autonomic failure, hypovolemia, or medications
- **Cardiac Syncope:** Due to arrhythmia or structural heart disease; highest mortality risk
- **Convulsive Syncope:** Syncope with brief myoclonic jerks (not epilepsy); due to cerebral hypoperfusion

---

**PRIORITY KEY:** STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting

---

## 1. LABORATORY WORKUP

### 1A. Core Labs (All Patients)

| Test | ED | HOSP | OPD | ICU | Rationale | Target Finding |
|------|:--:|:----:|:---:|:---:|-----------|----------------|
| Fingerstick glucose | STAT | STAT | ROUTINE | STAT | Hypoglycemia as cause | 70-180 mg/dL |
| CBC | ROUTINE | ROUTINE | ROUTINE | ROUTINE | Anemia; hemorrhage | Normal |
| BMP (electrolytes, creatinine) | ROUTINE | ROUTINE | ROUTINE | ROUTINE | Electrolyte abnormalities | Normal |
| Troponin | STAT | STAT | - | STAT | Cardiac ischemia as trigger | Negative |
| BNP or NT-proBNP | ROUTINE | ROUTINE | - | ROUTINE | Heart failure; risk stratification | Normal |
| Pregnancy test (if applicable) | STAT | STAT | ROUTINE | - | Ectopic pregnancy; influences workup | Document |

### 1B. Extended Labs (Based on Clinical Suspicion)

| Test | ED | HOSP | OPD | ICU | Rationale | Target Finding |
|------|:--:|:----:|:---:|:---:|-----------|----------------|
| TSH | - | ROUTINE | ROUTINE | - | Thyroid dysfunction | Normal |
| Cortisol (AM) | - | EXT | EXT | - | Adrenal insufficiency if orthostatic | Normal |
| D-dimer | URGENT | URGENT | - | URGENT | If PE suspected | Negative |
| Toxicology screen | ROUTINE | ROUTINE | - | - | Drug/alcohol-induced | Negative |
| Blood cultures | - | ROUTINE | - | ROUTINE | If infection suspected | Negative |

---

## 2. DIAGNOSTIC IMAGING & STUDIES

### 2A. Cardiac Studies (Priority Based on Risk)

| Study | ED | HOSP | OPD | ICU | Timing | Target Finding | Contraindications |
|-------|:--:|:----:|:---:|:---:|--------|----------------|-------------------|
| 12-lead ECG | STAT | STAT | ROUTINE | STAT | Immediate; ALL patients | No arrhythmia, normal intervals | None |
| Continuous telemetry | - | ROUTINE | - | ROUTINE | If admitted | No arrhythmia | None |
| Transthoracic echocardiogram | URGENT | ROUTINE | ROUTINE | URGENT | If cardiac cause suspected | Normal structure/function | None |
| Exercise stress test | - | ROUTINE | ROUTINE | - | If exertional syncope | No ischemia, no arrhythmia | Acute MI, unstable angina |
| Cardiac MRI | - | EXT | EXT | - | Suspected cardiomyopathy, ARVC | Normal or define pathology | Pacemaker, metal |

### 2B. Extended Cardiac Monitoring

| Study | ED | HOSP | OPD | ICU | Timing | Target Finding | Contraindications |
|-------|:--:|:----:|:---:|:---:|--------|----------------|-------------------|
| Holter monitor (24-48 hour) | - | - | ROUTINE | - | Frequent symptoms | Correlate symptoms with rhythm | None |
| Event recorder (2-4 weeks) | - | - | ROUTINE | - | Intermittent symptoms | Symptom-rhythm correlation | None |
| Insertable loop recorder (ILR) | - | - | ROUTINE | - | Infrequent, unexplained recurrent syncope | Identify arrhythmia | None |
| Electrophysiology study (EPS) | - | ROUTINE | EXT | - | Suspected arrhythmic cause; structural heart disease | Identify inducible arrhythmia | Active infection |

### 2C. Autonomic Testing

| Study | ED | HOSP | OPD | ICU | Timing | Target Finding | Contraindications |
|-------|:--:|:----:|:---:|:---:|--------|----------------|-------------------|
| Orthostatic vital signs | STAT | STAT | ROUTINE | STAT | Immediate; ALL patients | No orthostatic hypotension | None |
| Tilt table test | - | - | ROUTINE | - | Suspected vasovagal if recurrent; dx uncertain | Positive = cardioinhibitory or vasodepressor | Severe CAD, critical AS |
| Carotid sinus massage | - | ROUTINE | ROUTINE | - | Age >40 with unexplained syncope (not if carotid bruit) | Negative (<3 sec pause, <50 mmHg drop) | Carotid bruit, recent stroke/TIA |
| Autonomic function tests | - | - | ROUTINE | - | Suspected autonomic failure | Characterize dysautonomia | Per test |

### 2D. Neuroimaging (Select Cases Only)

| Study | ED | HOSP | OPD | ICU | Timing | Target Finding | Contraindications |
|-------|:--:|:----:|:---:|:---:|--------|----------------|-------------------|
| CT head | URGENT | ROUTINE | - | URGENT | Head trauma; focal neuro signs; NOT routine for syncope | No acute pathology | None (contrast: renal disease) |
| MRI brain | - | EXT | EXT | - | Atypical features suggesting CNS cause | Normal | Pacemaker, metal |
| EEG | - | EXT | EXT | - | If seizure suspected (prolonged LOC, postictal state, witnessed tonic-clonic) | No epileptiform activity | None |
| Carotid ultrasound | - | - | EXT | - | NOT indicated for typical syncope | N/A | None |

---

## 3. TREATMENT

### 3A. Acute Management (ED/Hospital)

| Treatment | ED | HOSP | OPD | ICU | Dosing | Contraindications | Monitoring |
|-----------|:--:|:----:|:---:|:---:|--------|-------------------|------------|
| IV access | STAT | STAT | - | STAT | Establish if unstable | None | Access |
| IV fluid resuscitation | STAT | ROUTINE | - | STAT | NS 500-1000 mL bolus if hypovolemic/dehydrated | Heart failure | Volume status |
| Trendelenburg position | STAT | ROUTINE | - | STAT | Legs elevated if hypotensive | None | BP |
| Telemetry monitoring | STAT | ROUTINE | - | ROUTINE | Continuous if high-risk | None | Arrhythmia |
| Correct reversible causes | STAT | STAT | - | STAT | Treat hemorrhage, dehydration, arrhythmia, MI | Per condition | Per condition |

### 3B. Vasovagal Syncope Treatment

| Treatment | ED | HOSP | OPD | ICU | Dosing | Contraindications | Monitoring |
|-----------|:--:|:----:|:---:|:---:|--------|-------------------|------------|
| Education and reassurance | ROUTINE | ROUTINE | ROUTINE | - | Benign prognosis; triggers; warning signs | None | None |
| Trigger avoidance | - | ROUTINE | ROUTINE | - | Identify and avoid (prolonged standing, heat, dehydration) | None | Recurrence |
| Counter-pressure maneuvers | - | ROUTINE | ROUTINE | - | Leg crossing, hand grip, arm tensing when prodrome felt | None | Effectiveness |
| Increased fluid/salt intake | - | ROUTINE | ROUTINE | - | 2-3 L fluid/day; 6-9 g salt/day (if no HTN/HF) | HTN, heart failure | BP |
| Compression stockings | - | - | ROUTINE | - | Waist-high, 30-40 mmHg | Peripheral vascular disease | Compliance |
| Tilt training | - | - | EXT | - | Progressive standing against wall; controversial efficacy | None | Tolerance |
| Fludrocortisone | - | - | ROUTINE | - | 0.1-0.2 mg daily (refractory cases) | HTN, HF | K+, BP, edema |
| Midodrine | - | - | ROUTINE | - | 2.5-10 mg TID (refractory cases) | Supine HTN, urinary retention | Supine HTN |

### 3C. Orthostatic Syncope Treatment

| Treatment | ED | HOSP | OPD | ICU | Dosing | Contraindications | Monitoring |
|-----------|:--:|:----:|:---:|:---:|--------|-------------------|------------|
| Identify/discontinue offending meds | STAT | STAT | ROUTINE | STAT | Review diuretics, vasodilators, antihypertensives | Clinical judgment | BP |
| Volume repletion | STAT | ROUTINE | ROUTINE | STAT | IV fluids acutely; oral fluids long-term (2-3 L/day) | Heart failure | Volume status |
| Salt supplementation | - | ROUTINE | ROUTINE | - | 6-10 g/day if no HTN/HF | HTN, HF | BP |
| Compression garments | - | - | ROUTINE | - | Waist-high stockings 30-40 mmHg; abdominal binder | PVD | Compliance |
| Elevate head of bed | - | ROUTINE | ROUTINE | - | 10-20 degrees at night (reduces nocturnal diuresis) | None | Tolerance |
| Midodrine | - | ROUTINE | ROUTINE | - | 2.5-10 mg TID; last dose before 6 PM | Supine HTN, urinary retention | Supine BP |
| Fludrocortisone | - | ROUTINE | ROUTINE | - | 0.1-0.3 mg daily | HTN, HF, hypokalemia | K+, BP |
| Droxidopa (Northera) | - | - | ROUTINE | - | 100-600 mg TID; for neurogenic orthostatic hypotension | Supine HTN | Supine BP |
| Pyridostigmine | - | - | EXT | - | 30-60 mg TID; augments ganglionic transmission | Asthma, GI obstruction | Cholinergic effects |

### 3D. Carotid Sinus Syncope Treatment

| Treatment | ED | HOSP | OPD | ICU | Dosing | Contraindications | Monitoring |
|-----------|:--:|:----:|:---:|:---:|--------|-------------------|------------|
| Avoid tight collars, neck pressure | - | ROUTINE | ROUTINE | - | Patient education | None | Recurrence |
| Dual-chamber pacemaker | - | ROUTINE | ROUTINE | - | If cardioinhibitory type (pause >3 sec) | None | Device checks |

### 3E. Cardiac Syncope Treatment

| Treatment | ED | HOSP | OPD | ICU | Dosing | Contraindications | Monitoring |
|-----------|:--:|:----:|:---:|:---:|--------|-------------------|------------|
| Treat underlying arrhythmia | STAT | STAT | ROUTINE | STAT | Per arrhythmia type | Per treatment | ECG, telemetry |
| Pacemaker | - | ROUTINE | ROUTINE | - | Sick sinus syndrome, high-grade AV block, bradycardia-induced syncope | None | Device checks |
| ICD (implantable cardioverter-defibrillator) | - | ROUTINE | ROUTINE | - | Ventricular arrhythmias; high-risk cardiomyopathy | Terminal illness | Device checks |
| Catheter ablation | - | ROUTINE | ROUTINE | - | Arrhythmia amenable to ablation (SVT, VT) | Extensive comorbidity | Recurrence |
| Treat structural heart disease | STAT | ROUTINE | ROUTINE | STAT | Aortic valve replacement for AS; revascularization for ischemia | Per condition | Per condition |

---

## 4. OTHER RECOMMENDATIONS

### 4A. Risk Stratification (San Francisco Syncope Rule, EGSYS, OESIL, Canadian Syncope Risk Score)

| High-Risk Features (Consider Admission) |
|-----------------------------------------|
| Abnormal ECG (new changes, arrhythmia, ischemia, prolonged QTc, Brugada pattern) |
| History of heart failure or reduced LVEF |
| Syncope during exertion |
| Syncope while supine or sitting |
| Family history of sudden cardiac death |
| Structural heart disease |
| Significant anemia or GI bleeding |
| Abnormal vital signs (persistent hypotension, bradycardia) |
| Elevated troponin or BNP |
| No prodrome (sudden syncope without warning) |
| Palpitations before syncope |
| Age >60 with first syncope |

### 4B. Referrals & Consults

| Recommendation | ED | HOSP | OPD | ICU | Indication |
|----------------|:--:|:----:|:---:|:---:|------------|
| Cardiology | URGENT | ROUTINE | ROUTINE | URGENT | Suspected cardiac syncope; abnormal ECG; structural heart disease |
| Electrophysiology | - | ROUTINE | ROUTINE | - | Arrhythmia evaluation; device consideration |
| Neurology | - | ROUTINE | EXT | - | If seizure suspected; atypical features |
| Autonomic disorders specialist | - | - | ROUTINE | - | Refractory orthostatic hypotension; complex dysautonomia |

### 4C. Patient/Family Instructions

| Recommendation | ED | HOSP | OPD |
|----------------|:--:|:----:|:---:|
| Recognize prodromal symptoms and immediately sit/lie down | ROUTINE | ROUTINE | ROUTINE |
| Counter-pressure maneuvers if prodrome (leg crossing, hand grip) | - | ROUTINE | ROUTINE |
| Avoid known triggers (prolonged standing, dehydration, heat) | - | ROUTINE | ROUTINE |
| Adequate hydration (2-3 L/day) and salt intake (if approved) | - | ROUTINE | ROUTINE |
| Rise slowly from lying/sitting; dangle legs before standing | - | ROUTINE | ROUTINE |
| Driving restrictions per state law; typically no driving until cause determined/treated | ROUTINE | ROUTINE | ROUTINE |
| Return if recurrent syncope, chest pain, palpitations, dyspnea | ROUTINE | ROUTINE | ROUTINE |

### 4D. Driving & Activity Restrictions

| Situation | Private Driving | Commercial Driving |
|-----------|-----------------|-------------------|
| Single vasovagal syncope with clear trigger | Usually OK immediately | Per regulations; often 3-12 months |
| Recurrent vasovagal syncope | Restrict until controlled | Often disqualifying |
| Unexplained syncope under investigation | Restrict until diagnosis | Restrict |
| Cardiac syncope (treated) | Per cardiologist; typically 6 months if ICD | Often disqualifying |
| Orthostatic syncope (treated) | When stable | Per individual assessment |

---

## 5. DIFFERENTIAL DIAGNOSIS

| Alternative Diagnosis | Key Distinguishing Features | Tests to Differentiate |
|-----------------------|----------------------------|------------------------|
| Seizure | Tonic-clonic activity, tongue biting, prolonged postictal state, incontinence | EEG; witness description |
| Stroke/TIA | Focal neurologic deficits; usually no LOC unless brainstem | CT/MRI; neuro exam |
| Hypoglycemia | Diaphoresis, tremor, confusion; diabetes/insulin use | Fingerstick glucose |
| Psychogenic pseudosyncope | Eyes closed (vs. open in true syncope); prolonged duration; normal vitals during event | Tilt table with video EEG |
| Drop attack | Sudden fall without LOC; no prodrome | History; normal during event |
| Cataplexy | Triggered by emotion; with narcolepsy | Sleep study; history |
| Cardiac arrest | No pulse during event; does not spontaneously recover | Witnessed event; no pulse |
| Concussion | Preceded by head trauma | History |
| Vertebrobasilar insufficiency | Vertigo, diplopia, dysarthria; rare cause of syncope | MRA; history |
| Pulmonary embolism | Dyspnea, pleuritic chest pain, hypoxia; syncope in massive PE | D-dimer, CT-PA |
| Aortic dissection | Tearing chest/back pain; BP differential | CT angiography |

## 6. MONITORING PARAMETERS

| Parameter | ED | HOSP | OPD | ICU | Frequency | Target/Threshold | Action if Abnormal |
|-----------|:--:|:----:|:---:|:---:|-----------|------------------|-------------------|
| Vital signs (including orthostatics) | STAT | q4-8h | Every visit | Continuous | Per setting | Stable; no orthostatic drop | Treat hypotension; volume |
| Continuous telemetry | - | Continuous | - | Continuous | Until risk stratified | No arrhythmia | Cardiology consult |
| ECG | STAT | Daily | Every visit if cardiac | STAT | Per clinical status | No new changes | Cardiology; treatment |
| Troponin | STAT | q6-8h Ã— 2 if initially elevated | - | Per cardiac status | Until ruled out | Negative | Cardiology |
| Recurrence | - | Ongoing | Every visit | - | Ongoing | No recurrence | Re-evaluate diagnosis/treatment |

## 7. DISPOSITION CRITERIA

| Disposition | Criteria |
|-------------|----------|
| Discharge from ED | Low-risk syncope (vasovagal with clear trigger, normal ECG, normal vitals, no cardiac history); reliable follow-up |
| Admit to telemetry | High-risk features (abnormal ECG, cardiac history, exertional, no prodrome, abnormal vitals); unexplained syncope in elderly |
| ICU admission | Hemodynamically unstable; malignant arrhythmia; acute MI; massive PE |
| Syncope unit/observation | Intermediate risk; brief observation with monitoring |
| Cardiology follow-up | Suspected cardiac cause; abnormal echo; need for device evaluation |
| Neurology follow-up | Atypical features suggesting seizure or neurologic cause |
| Primary care follow-up | Low-risk vasovagal syncope; medication review for orthostatic |

## 8. EVIDENCE & REFERENCES

| Recommendation | Evidence Level | Source |
|----------------|----------------|--------|
| ECG for all syncope patients | Class I, Level B | ESC 2018 Syncope Guidelines |
| Echo if cardiac cause suspected | Class I, Level B | ESC 2018; AHA/ACCF 2017 |
| Tilt test for recurrent vasovagal syncope | Class IIa, Level B | ESC 2018 |
| Pacemaker for cardioinhibitory carotid sinus syncope | Class I, Level B | ESC 2018 |
| ILR for recurrent unexplained syncope | Class I, Level A | ISSUE-3 trial; ESC 2018 |
| Counter-pressure maneuvers for vasovagal | Class IIa, Level B | PC-Trial |
| Midodrine for refractory orthostatic hypotension | Class IIa, Level B | Multiple RCTs |
| Risk stratification scores (Canadian Syncope Risk Score) | Class IIa, Level B | Thiruganasambandamoorthy et al. |

---

## NOTES

- Syncope is common (1-3% of ED visits); most are benign reflex syncope
- Cardiac syncope has highest mortality (up to 30% at 1 year); must be ruled out
- The history is the most important diagnostic tool (triggers, prodrome, position, witnesses)
- "Red flags" for cardiac syncope: exertional, supine, no prodrome, family history SCD, structural heart disease
- ECG is mandatory for ALL syncope patients
- Routine neuroimaging (CT, MRI) is NOT indicated for typical syncope without focal signs
- EEG is NOT indicated unless seizure is suspected
- Convulsive syncope (brief myoclonic jerks) is common and does NOT indicate epilepsy
- Insertable loop recorder (ILR) has high diagnostic yield for unexplained recurrent syncope
- Driving restrictions vary by state/country; counsel patients appropriately
- Many patients do not require extensive workup if history clearly suggests vasovagal syncope

---

## CHANGE LOG

**v1.0 (January 29, 2026)**
- Initial template creation
- Risk stratification criteria included
- Treatment by syncope type (vasovagal, orthostatic, cardiac, carotid sinus)
- Driving restrictions addressed
- ESC 2018 guidelines incorporated
